Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fortune Mate Indonesia Tbk (FMII) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Fortune Mate Indonesia TbkTrade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Fortune Mate Indonesia Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fortune Mate Indonesia Tbk trades at Rp254 (market cap 1.63T, 5.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Fortune Mate Indonesia Tbk is far larger — about 9.8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (324K versus 5.8K). Which is the better fit depends on your goals.

FMIIOBAT
Market Cap
1.63T166.01B
Volume
5.8K324K
Lot
583.24K
Turnover
1.45M77.68M
Average Price
249.52239.75
Value
1.45M77.68M
Indicative Equilibrium Price
254240
Indicative Equilibrium Volume
11

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

FMII
View details
OBAT
View details

About Fortune Mate Indonesia Tbk

PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.

Read more on FMII

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT